BCC Process

  • How we fill the gap

BCC Sits at the Intersection of Science, Strategy & Markets

Clarify The Science
  • Indication prioritization & pipeline strategy
  • Differentiation vs. Standard of Care (SOC)
  • Regulatory feasibility assessment
  • Clinical trial design (Phase 0–III)
  • Target Product Profile (TPP) & Integrated Development Plan (IDP) refinement
Quantify The Opportunity
  • Market sizing (TAM/SAM) & forecasting
  • Patient journey mapping & segmentation
  • Pricing & market access signals (US/Ex-US)
  • Go-to-Market (GTM) models
  • Asset valuation & DCF modeling
Communicate The Value
  • Investor narratives & fundraising pitches
  • Business Development (BD) opportunity identification
  • Diligence support (buy-side & sell-side)
  • M&A and IPO readiness
  • S-1 / Prospectus support

Acquirers do not buy narratives alone. They buy de-risked opportunities. That means a company must understand what evidence, diligence materials, competitive analysis, commercial logic, and integration story a buyer will need before the company enters the room."

  • Our Engagement Model

The BCC 6-Week Sprint

01

Week 1-2

Foundation

  • Stakeholder alignment & interviews

  • Data collection & review

  • Strategic gap analysis

02

Week 2–3

Insights

  • Market analysis & sizing

  • Competitive landscape mapping

  • Clinical-commercial alignment

03

Week 4–5

Refinement

  • Pricing & valuation analysis

  • Narrative development

  • Scenario modeling

04

Week 6

Delivery

  • Strategic recommendations

  • Investor / BD-ready materials

  • Final strategy deck

Extended engagements upon request for ongoing or fractional support & implementation
  • Flexible Engagement Options

Right-Sized for Your Stage

  • Flexible Engagement Options

Right-Sized for Your Stage

Strategic Advisory

Focused guidance, executive workshops, and leadership sessions to align stakeholders on critical decisions.

Fractional Embedded Leadership

Senior executive embedded within your team (e.g., Fractional CCO) to drive commercial execution without the overhead of a full-time hire.

Project Implementation

End-to-end project delivery with a defined scope, timeline, and deliverables. Ideal for indication prioritization, TPP development, or market sizing.

Bespoke Ongoing Support

Continuous advisory retainer tailored to evolving needs. Provides flexible access to our team's expertise as your company grows.

  • Appendix

Common Questions About Working with BCC

How quickly can BCC get started?
We can mobilize within 5–7 business days. Our structured onboarding process ensures immediate strategic alignment without a prolonged ramp-up period, allowing us to deliver actionable insights from week one.

Yes. Our team has deep experience across US, EU, Japan, and APAC markets. We regularly support global market access planning, ex-US licensing deals, and international launch strategies tailored to local regulatory environments.

We offer integrated clinical-commercial-financial expertise under one roof. Unlike a single fractional executive, you get the judgment of a seasoned C-suite leader backed by a full team of specialists—providing broader capabilities without the overhead.
All engagements are custom-scoped based on your specific needs. We offer flexible models including project-based fees, monthly retainers, and fractional embedded leadership. Contact us for a no-commitment discovery call.

IPO readiness starts before the IPO window opens. The companies that move fastest when markets recover are often the ones that have already disciplined their story, governance, financial controls, risk factors, development milestones, and investor-facing narrative.